Neurocognitive function in HIV infected patients on antiretroviral therapy - Wikidata - wikimedia - TriplyDB

Neurocognitive function in HIV infected patients on antiretroviral therapy

Neurocognitive function in HIV infected patients on antiretroviral therapy

http://www.wikidata.org/entity/Q34706686

about

HIV-1 transgenic female rat: synaptodendritic alterations of medium spiny neurons in the nucleus accumbens.Defining cognitive impairment in people-living-with-HIV: the POPPY study.Neurocognitive function in HIV-infected patients: comparison of two methods to define impairment Minimal cognitive impairment in UK HIV-positive men who have sex with men: effect of case definitions and comparison with the general population and HIV-negative men HIV-associated neurocognitive disorder in Australia: a case of a high-functioning and optimally treated cohort and implications for international neuroHIV research Controversies in HIV-associated neurocognitive disorders A better screening tool for HIV-associated neurocognitive disorders: is it what clinicians need?Identifying Neurocognitive Decline at 36 Months among HIV-Positive Participants in the CHARTER Cohort Using Group-Based Trajectory Analysis.Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial.Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT Trial.Primary care of women aging with HIV.Role of P-glycoprotein in the distribution of the HIV protease inhibitor atazanavir in the brain and male genital tract.Pharmacokinetics and pharmacodynamics of antiretrovirals in the central nervous system.Cognitive Function in Young Persons With and Without Perinatal HIV in the AALPHI Cohort in England: Role of Non-HIV-Related Factors.Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.Multicenter European Prevalence Study of Neurocognitive Impairment and Associated Factors in HIV Positive Patients.Impact of efavirenz pharmacokinetics and pharmacogenomics on neuropsychological performance in older HIV-infected patients.Factors associated with neurocognitive test performance at baseline: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.Pattern of neurocognitive function in patients receiving boosted protease inhibitor monotherapy: a detailed neuropsychological study.Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS.A Gap in Time: Extending our Knowledge of Temporal Processing Deficits in the HIV-1 Transgenic Rat.The 'COmorBidity in Relation to AIDS' (COBRA) cohort: Design, methods and participant characteristics.HIV-associated cognitive performance and psychomotor impairment in a Thai cohort on long-term cART.

P2860

Q30397434-449BE6ED-FCE6-4786-ADE2-25FA93F9A204 Q30826784-40148811-155D-4DC0-99D1-360CA1FE0BB0 Q33982015-88912469-CB1F-4D5B-9FB9-3507A7827C3B Q34243885-468DF88D-899F-4D66-A851-0BF97AEA0EF3 Q34721127-4E102F7C-6216-42D4-B919-8A148111F30D Q35037015-67E8581D-51B3-4875-913E-CBCFA27603B4 Q35648919-FCF537F2-4526-49C9-A11E-C5E5D11D6684 Q36020991-0CEC417F-A4F2-4EE1-9A3C-5904F5A67F06 Q36613143-6ABE8DFC-D8CF-4553-A2A6-F30FC960FFEC Q37055030-CC5E1901-FB72-458B-A3C4-AF4262CD1120 Q37272968-69394902-1845-4586-84EF-937312BF3165 Q37643618-3A224DBC-9FC3-4B2E-A018-5903B9A5C5EE Q38247035-E69DFD17-138A-42CA-8855-857455764699 Q39434442-0BCAF56E-5DDC-4B5B-B63B-E5D247484933 Q39598073-18891448-FCD9-4329-A2E0-A2C2A06A3F2B Q40350913-1880140F-BF25-4435-9DA0-457F330C2563 Q40531475-471493C8-A568-4E08-9ED4-0E39E783738F Q41466517-5A1129DC-1FBB-4463-A0A1-13473714F5F4 Q42222663-1D64B4A2-4E92-4F94-B21F-236BBCAB9F1B Q47329123-5A7480C9-FE9B-481D-BA6C-654CCC66385B Q47989010-F6BB7846-BC44-4B4F-9F37-2F69F2DB1300 Q51758448-15A1019A-0EEF-4B30-8C2D-22AC143F9850 Q51760388-092CAF07-E90F-4D57-A8FD-937014FECC2A

P2860

Neurocognitive function in HIV infected patients on antiretroviral therapy

http://www.wikidata.org/entity/Q34706686

description

2013 nî lūn-bûn

@nan

2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Neurocognitive function in HIV infected patients on antiretroviral therapy

@ast

Neurocognitive function in HIV infected patients on antiretroviral therapy

@en

Neurocognitive function in HIV infected patients on antiretroviral therapy

@nl

type

label

Neurocognitive function in HIV infected patients on antiretroviral therapy

@ast

Neurocognitive function in HIV infected patients on antiretroviral therapy

@en

Neurocognitive function in HIV infected patients on antiretroviral therapy

@nl

prefLabel

Neurocognitive function in HIV infected patients on antiretroviral therapy

@ast

Neurocognitive function in HIV infected patients on antiretroviral therapy

@en

Neurocognitive function in HIV infected patients on antiretroviral therapy

@nl

P1433

Q34706686-ECD36601-19FE-4B5B-BD8E-00DD1D55C564

P1476

Q34706686-149F2E0D-A414-49D0-95B5-85650E17744C

P2093

Q34706686-13E4454D-7BA9-4BA8-9D4D-7C63B50E75C2

Q34706686-35D8619C-30EA-4031-AF47-AE75C91C1C0B

Q34706686-3C7C24B8-2B4D-40A2-BBF3-B9F432C247EF

Q34706686-433D7714-0667-443C-9A3B-298144CBE135

Q34706686-454CFCEF-6CAF-4175-A4A0-467A893E6E55

Q34706686-46AF77CF-A958-46C1-B9B4-FC76DF74FD5B

Q34706686-4B737DEF-1D57-44C1-8A9C-B05E7161A735

Q34706686-4ED45575-11C7-44D5-9256-1EF6E9485B25

Q34706686-5D74C8BC-82AD-47F6-B220-BC7D16F16F77

Q34706686-8E4B6B04-72DC-45C5-B5D5-8466DF8C8BBE

P2860

Q34706686-0C2DD3C0-AD6A-4EE3-A4C1-00D23457B4C9

Q34706686-0C75095B-B3EA-4B01-B0D5-A7B3857E31E9

Q34706686-25969C3C-9B05-4E69-9BC5-9D7A28F9DBB3

Q34706686-28A25D7C-63EE-4AA6-AA9A-0D2A7365B77D

Q34706686-2B5FE2D4-8BC1-4BD8-BF7A-83743644849A

Q34706686-2B817E06-C9D1-46A2-B99D-D2C99A279F81

Q34706686-2D476ECE-3E8F-453D-B94C-95D5A27A0A3F

Q34706686-3713141A-729E-4359-9DDB-5CAF3F131C38

Q34706686-4502329E-3542-48A4-91E6-E6D13F6765E0

Q34706686-4F4A323E-1AA8-474A-871D-7C5038FD12A8

P304

Q34706686-D66CD048-7546-45D6-943A-2513C1FBAFE8

P31

Q34706686-E2082781-1202-4990-B2E5-BD67522A9CC5

P356

Q34706686-A1D812A1-2C88-47CC-8245-3155FEF18F5E

P407

Q34706686-603E3F44-93E8-4452-B3FC-1427B1865F2F

P433

Q34706686-C5299A20-6546-4F59-8C1D-1459548056BC

P478

Q34706686-F734B198-5EA1-44AF-B836-7AD4F4A2DFE7

P50

Q34706686-A78B0493-7287-4ABA-961C-F1E732757445

P577

Q34706686-B894A1A2-E7CA-42A9-8556-008990A48111

P5875

Q34706686-D3A0C2C2-6CB7-4B5E-BC96-412C76A8F212

P698

Q34706686-F10C1618-5EE3-497C-AF23-123D74B73EFB

P921

Q34706686-6C5F1AE3-5098-4AA7-A241-27E8AB52E918

P932

Q34706686-6FD61A21-ED61-4FD9-9C40-97C8AA935AE9

P356

JOURNAL.PONE.0061949

P1433

P1476

Neurocognitive function in HIV infected patients on antiretroviral therapy

@en

P2093

Alan Winston

http://www.w3.org/2001/XMLSchema#string

Alejandro Arenas-Pinto

http://www.w3.org/2001/XMLSchema#string

Andrew De Burgh-Thomas

http://www.w3.org/2001/XMLSchema#string

Charles Jn Lacey

http://www.w3.org/2001/XMLSchema#string

Chloe M Orkin

http://www.w3.org/2001/XMLSchema#string

Clifford Leen

http://www.w3.org/2001/XMLSchema#string

David Dunn

http://www.w3.org/2001/XMLSchema#string

Kazeem Aderogba

http://www.w3.org/2001/XMLSchema#string

Martin Fisher

http://www.w3.org/2001/XMLSchema#string

Nicholas I Paton

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors

Functional polymorphisms in dopamine-related genes: effect on neurocognitive functioning in HIV+ adults.

Neuropsychiatric impact of hepatitis C on advanced HIV

Demographically corrected norms for African Americans and Caucasians on the Hopkins Verbal Learning Test-Revised, Brief Visuospatial Memory Test-Revised, Stroop Color and Word Test, and Wisconsin Card Sorting Test 64-Card Version.

Screening for cognitive impairment in human immunodeficiency virus.

Updated research nosology for HIV-associated neurocognitive disorders

JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice.

Relationship of ethnicity, age, education, and reading level to speed and executive function among HIV+ and HIV- women: the Women's Interagency HIV Study (WIHS) Neurocognitive Substudy

Dynamics of cognitive change in impaired HIV-positive patients initiating antiretroviral therapy

Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system

P304

e61949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0061949

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang Stöhr

P577

2013-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258809048

http://www.w3.org/2001/XMLSchema#string

P698

23646111

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

3639991

http://www.w3.org/2001/XMLSchema#string